In contrast to the hyperactive expression at baseline, skin fibroblasts from CHS individuals exhibit marked hyporesponsiveness to LPS challenge, failing to alter production of chemokines and cytokines including CCL-7, IL-10, IL-15, IL-18, IL-1A, and IL-23A. This evidence concerns the gene IL15 and Chediak-Higashi syndrome.